Sign inJoin waitlistJoin the waitlist

Mark Mishra

Physician · Maryland Proton Treatment Center

Credentials: · · · · ·

History

Maryland Proton Treatment Center
Present

Internal Medicine
Thomas Jefferson University Hospital
2010–2013
Radiation Oncology
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
2009–2013
Evanston Northwestern Hospital of McGaw Medical Center
2008–2009
Chan School of Public Health
University of Cincinnati College of Medicine
2004–2008

Research

SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression
International Journal of Biological Sciences · 2008 · 250 citations
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Journal of Clinical Oncology · 2022 · 230 citations
A systematic review of the cost and cost-effectiveness studies of proton radiotherapy
Systematic review or meta-analysis · Cancer · 2016 · 186 citations

Timothy Showalter
20 papers
Adam Dicker
15 papers
Jason Molitoris
14 papers
Xinglei Shen
12 papers · 8 as a resident
Colin Champ
11 papers · 9 as a resident
Zaker Rana
11 papers · 1 as a resident
Graeme Woodworth
10 papers
Joshua Palmer
10 papers
Minesh Mehta
10 papers
Elizabeth Nichols
9 papers
Phuoc Tran
9 papers
Young Kwok
9 papers

Grants

Proposal for NCI Research Specialist (Clinician Scientist) Award
National Cancer Institute · R50
Contact PI · $375K · University of Maryland Baltimore
2025–2029
University of Maryland Greenebaum Cancer Centersupport Grant
National Cancer Institute · P30
Project lead · $94.7K · University of Maryland Baltimore
2018–2021

Clinical trials

Prostate Cancer Survey
Principal investigator · Completed
University of Maryland, Baltimore
2017–2018
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Site PI · Recruiting · Phase 3
NRG Oncology
2026–2035
REMASTer: REcurrent Brain Metastases After SRS Trial
Site PI · Recruiting
Monteris Medical
2022–2028
Registry Study for Radiation Therapy Outcomes
Site PI · Recruiting
Proton Collaborative Group
2009